Trump froze out project 2025 in his campaign. Now its blueprint is his health care playbook.

Few voters likely expected President Donald Trump in the first weeks of his administration to slash billions of dollars from the nation’s premier federal cancer research agency.

Galimedix Therapeutics initiates pivotal Phase 2 study with GAL-101 eye drops in dry AMD – Biotech Investments

EQS-News: Galimedix, Inc. / Key word(s): Study Galimedix Therapeutics initiates pivotal Phase 2 study with GAL-101 eye drops in dry AMD 23.12.2024 / 17:30 CET/CEST

December 24, 2024

Increased stiffness in aging skin may contribute to higher rates of metastatic skin cancer

Age-related changes that cause the skin to stiffen and become less elastic may also contribute to higher rates of metastatic skin cancer in older people,

March 12, 2024

J&J discontinues mid-stage dengue study, citing deprioritization of communicable disease work

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.